Amiodarone-induced thyrotoxicosis (AIT) remains a challenging problem, often posing difficulties in diagnosis and therapy. Two types of AIT exist and are classified according to their etiology.

Thyrotoxicosis is a well-documented and studied complication of treatment with amiodarone, but little has been written about the risks and treatment of recurrent thyrotoxicosis upon re-exposure to ...

Type I is iodine-induced hyperthyroidism, which develops in those with underlying thyroid disease, type II is amiodarone-induced destructive thyroiditis. Type I AIT typically occurs in those with ...

The use of amiodarone can cause thyrotoxicosis by activating latent nodules — triggering Graves’ disease — or by causing a destructive thyroiditis. Thyrotoxicosis can occur up to 1 year ...

Lancet 1997; 350: 1417–24. MEDLINE 2. Trip MD, Wiersinga WM, Plomp TA: Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991 ...